Hyperinflammatory Syndromes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA vaccination in Individuals With Underlying Immune Dysregulation

The development of effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines has been a significant accomplishment. Adverse events are extremely rare, but continued surveillance is important, especially in at-risk populations. In 5 patients with preexisting...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocco, Joseph M, Mallarino-Haeger, Christina, Randolph, Attiya H, Ray, Susan M, Schechter, Marcos C, Zerbe, Christa S, Holland, Steven M, Sereti, Irini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689836/
https://www.ncbi.nlm.nih.gov/pubmed/34893818
http://dx.doi.org/10.1093/cid/ciab1024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689836/
https://www.ncbi.nlm.nih.gov/pubmed/34893818
http://dx.doi.org/10.1093/cid/ciab1024

Ejemplares similares